维普中文期刊产品整合服务
13篇 您的检索式:作者名="Warren AD"
    题名 作者 年代 出处 被引量
1Bryostatins trigger human polymorphonuclear neutrophil and monocyte oxidative metabolism:association with in vitro antineoplastic activity显示文摘 Warren JT Hess AD 1995Res Immunol1995,146,6:1
2Basic science of articular carti- lage and osteoarthritis 显示文摘Pearle AD Warren RF Rodeo SA 2005Clin Sports Med2005,24,1:1
3The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo显示文摘Lucas AD Chadwick N Warren BF 2001Am J Pathol2001,158,3:1
4The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo显示文摘Lucas AD Chadwick N Warren BF 2001Am J Patho12001,158,3:1
5Point-of-care diagnostics for noncommunicable diseases using synthetic urinmy biomarkers and paper microfluidics显示文摘Warren AD Kwong GA Wood DK 2014Proc Natl Acad Sci USA2014,111,10:1
6The transmembrane form of the CX3CLI chemokine fractalkine is expressed predominantly by epithelial cells in vivo显示文摘Lucas AD Chadwick N Warren BF 2001Am J Pathol2001,158,3:1
7The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo 显示文摘Lucas AD Chadwick N Warren BF 2001Am J Pathol2001,158,3:1
8Basic science of articular cartilage and osteoarthrltis显示文摘Pearle AD Warren RF Rodeo SA 2005Clin Sports Med2005,24,1:1
9The pivot shift 显示文摘Lane CG Warren R Pearle AD 2008J Am Acad Orthop Surg2008,16,12:1
10Determination of fluoride ion by turbidimetric titration 显示文摘 Allen AD 1958Anal Chem1958,30,6:1
11Basic science of articular cartilage and osteoarthritis 显示文摘Pearle AD Warren RF Rodeo SA 2005Clin Sports Med2005,24,:1
12The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo显示文摘Lucas AD Chadwick N Warren BF 2001Am J Pathol2001,158,3:1
13生物制剂治疗银屑病患者出现严重感染的风险评估:一项系统性回顾与荟萃分析显示文摘肿瘤坏死因子抑制剂英夫利昔单抗、依那西普和阿达木单抗是目前用于治疗银屑病常用的3种生物制剂,新药优特克单抗是IL-12和IL-23拮抗剂,苏金单抗是IL-17受体拮抗剂。生物制剂通过抑制细胞因子,调控银屑病患者紊乱的免疫系统,从而发挥疗效。肿瘤坏死因子等细胞因子在细胞感染免疫应答和肉芽肿形成过程中是不可或缺的重要一员,因此生物治疗是否存在引起严重感染的风险是临床医师非常关注的问题。目前缺乏对生物制剂治疗银屑病引起严重感染风险的综合评估。Yiu ZZ Exton LS Jabbar-Lopez Z Mohd Mustapa MF Samarasekera EJ Burden AD Murphy R Owen CM Parslew R Venning V Ashcroft DM Griffiths CE Smith CH Warren RB 薛如君 张锡宝 2017皮肤性病诊疗学杂志2017,24,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费